PI3K/Akt Survival Pathway Parallel to cAMP signaling, GLP-1 receptor activation stimulates the phosphatidylinositol 3-kinase (PI3K)/Akt pathway, a critical mediator of cell survival and metabolic regulation
Orlistat-associated adverse effects and drug interactions: a critical review
This research material is not an investigational drug product, has not been evaluated by the FDA for any use, and is not intended for clinical, diagnostic, or veterinary applications
2003 Oct;24(5):610-28 Zhou J, Roane DS, Xi X, Bogacka I, Li B, Ryan DH, Martin RJ
Both are GLP-1 receptor agonists, but Rybelsus is currently FDA approved only for managing type 2 diabetes
Risk factors for thyroid cancer: A hospital-based case-control study in Korean adults